Читать книгу Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting - Tamilvanan Shunmugaperumal - Страница 49

2.5.1.6. Response Surface Plot Analysis

Оглавление

The 3D response surface graphs for the selected CQAs (R1:MPS, R2:PDI, and R3:ZP) of topical ophthalmic emulsions are shown in Fig. 2.6. To represent the 3D graphs for R1 (MPS), there are three different plots designated as Fig. 2.6a–c. In a similar way, the 3D graphs for R2 (PDI) and R3 (ZP) are also represented, respectively, as Fig. 2.6d–f and Fig. 2.6g–i. From Fig. 2.6a and b, the MPS value increases with an increase in the amount of castor oil. Two possible explanations might be provided with this observation. The oil droplet disruption process during homogenization and probe sonication of coarse emulsion gets somewhat cumbersome due to the progressive increment of castor oil amount because of the resistance in oil flow and thus the diminution/restriction in the oil droplet breakup rate. The MPS value increase due to the increase of castor oil amount might also be attributed to the increased rates of oil droplets—droplets collision frequency especially at lower castor oil amount, which ultimately leads to the higher probability of coalescence of the smaller droplets and thus the bigger droplet formation at the expense of smaller droplets.


Figure 2.6. Response surface plots showing the interaction effects of castor oil and chitosan (a, d, g), castor oil and poloxamer (b, e, h), and chitosan and poloxamer (c, f, i) on response, mean particle size (R1), polydispersity index (R2), and zeta potential (R3), respectively.

The presence of two different emulsifying agents (chitosan and poloxamer) either alone or in combination influenced the MPS in a biphasic manner. An initial increment until to reach a sharp break‐point followed by a progressive decrement in the MPS value was noticed when these two emulsifying agents interacted (Fig. 2.6c) as well as even in the occurrence of interaction between chitosan and castor oil (Fig. 2.6a) or poloxamer and castor oil (Fig. 2.6b). The initial particle size increment might be due to an inadequate amount of emulsifying agent(s) to form a mono‐ or multilayer film onto the dispersed oil droplets of the emulsion during emulsification (Jumaa and Müller 1998). Due to the attainment of the critical interfacial tension reduction at the vicinity of oil and water by the sufficient amount of emulsifying agent(s) resulted in the diminution of Laplace pressure, p, and thus the stress required for droplet deformation is reduced (Tang et al. 2012).

The PDI value is ranged from 0 to 1 wherein PDI < 0.1 indicates a nearly homogenous monodisperse formulation. The PDI value between 0.1 and 0.2 specifies a particle population with relatively narrow size distribution while the PDI > 0.3 designates polydispersity with variations in particle size without a distinct distribution shape (Müllar 1990; Cegnar et al. 2004). The experimental CPPs involved in the preparation of topical ophthalmic emulsions may influence the performance of CQAs (PDI). All of the studied CPPs (amounts of castor oil, chitosan, and poloxamer) produced a direct relationship with PDI values observed. An increase in CPPs amounts increases the PDI values (Fig. 2.6d–f). Higher is the amount of castor oil, lesser is the oil breakdown frequency during emulsification promoting the formation of larger sized oil droplets and thus the PDI to attain a higher value. Increasing the amounts of these two emulsifying agents (chitosan and poloxamer) either alone (Fig. 2.6d and e) or in combination (Fig. 2.6f) also increased the PDI values. For instance, the PDI value of >0.6 was noted when the interaction between chitosan and castor oil occurred (Fig. 2.6d). But the interaction between poloxamer and castor oil yielded the PDI value of ~0.6 (Fig. 2.6e). However, the combined interaction of two emulsifying agents produced the PDI value of <0.6 (Fig. 2.6f). These effects are possibly due to the progressive increase in the apparent viscosity of the emulsion, which ultimately provides a higher flow resistance in the batch emulsification process (Müllar 1990). In consequence, this condition increased the coalescence rate resulting in a large particle size to form. Moreover, the large particles with inadequate emulsifier film coverage tend to coalesce faster than small particles. This phenomenon contributed to the high PDI value. Figure 2.6g–i demonstrates that by increasing the chitosan or castor oil concentration, the ZP value increases. In contrast, a biphasic manner, i.e., an initial increase followed by decrease in the ZP values, was observed with an increase in poloxamer concentration (Fig. 2.6h and i). It should be added that the present topical ophthalmic emulsions were stabilized by both electrostatic and steric mechanisms due to the chitosan and poloxamer emulsifier combination. Whatever the strong repulsive Coulomb force occurred between the protonated chitosan molecules must be counterbalanced by the week van der Waals attraction forces or the steric hindrance effect of poloxamer. That is why the biphasic attitude was seen for the influence of poloxamer concentration on ZP values (Tamilvanan 2009).

Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting

Подняться наверх